Page last updated: 2024-10-15

chloroacetaldehyde and Leukemia

chloroacetaldehyde has been researched along with Leukemia in 1 studies

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research Excerpts

ExcerptRelevanceReference
"Alkylation of DNA by acrolein and/or chloroacetaldehyde may result in the mutations that lead to the therapy-induced leukemia associated with cyclophosphamide (and ifosfamide) treatment."3.71Modified guanines representing O(6)-alkylation by the cyclophosphamide metabolites acrolein and chloroacetaldehyde: synthesis, stability, and ab initio studies. ( Balu, N; Colvin, ME; Colvin, OM; Dolan, ME; Gamcsik, MP; Ludeman, SM, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balu, N1
Gamcsik, MP1
Colvin, ME1
Colvin, OM1
Dolan, ME1
Ludeman, SM1

Other Studies

1 other study available for chloroacetaldehyde and Leukemia

ArticleYear
Modified guanines representing O(6)-alkylation by the cyclophosphamide metabolites acrolein and chloroacetaldehyde: synthesis, stability, and ab initio studies.
    Chemical research in toxicology, 2002, Volume: 15, Issue:3

    Topics: Acetaldehyde; Acrolein; Alkylation; Antineoplastic Agents, Alkylating; Cyclophosphamide; DNA Damage;

2002